Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours Β· Estimated delivery Aug 27 - Sep 1
Real Medications
[3] The GLP-1 and GIP arms deliver the incretin effects now familiar from drugs like semaglutide and tirzepatide appetite suppression, slowed gastric emptying, and improved glucose handling
Emerging role of GLP-1 agonists in cardio-metabolic research protocol Focus on [PMID: 40115122] Laboratory literature summary: Emerging role of GLP-1 agonists in cardio-metabolic research protocol Focus on Semaglutide
Individual response determines optimal maintenance strategy
Retatrutide 60mg is our maximum-strength research peptide vial, containing 60mg of the GIP/GLP-1/glucagon triple agonist Retatrutide as a lyophilised powder, for laboratory research use only
US$ 24.10
US$ 20.09
US$ 20.97
US$ 24.18
US$ 21.22
US$ 26.43
US$ 23.27
US$ 29.19
